Sustainability | September 12, 2023
JB Pharma publishes sustainability report for FY 2022-23
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Good momentum in commercial CDMO business
Effective disaster response and management is a collaborative work
Concept Medical’s manufacturing arm has reduced its carbon footprint via in-house efficiency improvement programmes & green infrastructure
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
This will enable the company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant
Q2 FY23 business performance has been slow primarily due to lower volume offtake from pharmaceutical manufacturers
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Subscribe To Our Newsletter & Stay Updated
